Zobrazeno 1 - 10
of 651
pro vyhledávání: '"Kristian Reich"'
Autor:
Kristian Reich, Luca Bianchi, Abdallah Khemis, Julia-Tatjana Maul, Athanasios Tsianakas, Christoph M. Schempp, Kim Petersen, Mia M. Noergaard, Lluis Puig
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 2, Pp 453-468 (2024)
Abstract Introduction Despite improved treatment options for plaque psoriasis within the last decades, some patients still have an inadequate response to treatment. Direct clinical evaluation between therapies used after biologic failure could facili
Externí odkaz:
https://doaj.org/article/f09ca6c5e0ca4fdfaf20f1b1d0aab3bd
Autor:
Byung Soo Kim, Seong Jin Jo, SangWoong Youn, Kristian Reich, Carine Saadoun, Chia-Ling Chang, Ya-Wen Yang, Yu-Huei Huang, Tsen-Fang Tsai
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2721-2737 (2023)
Abstract Introduction Guselkumab is a human monoclonal antibody against IL-23 used in the treatment of moderate-to-severe psoriasis. This post-hoc analysis evaluated the efficacy and safety of guselkumab in the Asian subpopulation of VOYAGE 1 and VOY
Externí odkaz:
https://doaj.org/article/2b7c6fb033354599855853fa87c33387
Autor:
James Signorovitch, Joris Diels, Suzy Van Sanden, Agata Schubert, Fareen Hassan, Pushpike Thilakarathne, Bulent Ozturk, Norma Barthelmes, Kristian Reich
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Head-to-head comparisons through randomized controlled trials (RCTs) provide high-quality evidence to inform healthcare decisions. In their absence, indirect comparisons are often performed; however, evidence is limited on how valid matchi
Externí odkaz:
https://doaj.org/article/180db56a99b1486290be626f0ece6d68
Autor:
Kristian Reich, Ulrich Mrowietz, Christina Sorbe, Ralph von Kiedrowski, Sebastian Diemert, Lisa Schaeffer, Natalia Kirsten, Nesrine Ben-Anaya, Matthias Augustin
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 8, Pp 3170-3177 (2022)
Objectives Fumaric acid esters (FAEs) are a well-established treatment option for long-term therapy of moderate to severe plaque psoriasis. This study examines effectiveness of FAEs for the treatment of plaque psoriasis in real-world practice at 12 m
Externí odkaz:
https://doaj.org/article/48ad2419189b4495a240f13a45f949a6
Autor:
Andrew Blauvelt, April W. Armstrong, Richard G. Langley, Kurt Gebauer, Diamant Thaçi, Jerry Bagel, Lyn C. Guenther, Carle Paul, Bruce Randazzo, Susan Flavin, Ming-Chun Hsu, Yin You, Kristian Reich
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 4, Pp 2317-2324 (2022)
Purpose Guselkumab, an interleukin (IL)-23 inhibitor, effectively treats moderate-to-severe plaque psoriasis. Materials and methods ECLIPSE, was a Phase 3, multicenter, 56-week, double-blinded, active-comparator study of guselkumab vs. secukinumab (I
Externí odkaz:
https://doaj.org/article/6ec5a4f2af80459bbcccd036201c48cc
Autor:
Alexander Nast, Corinna Dressler, Christopher Schuster, Daniel Saure, Matthias Augustin, Kristian Reich
Publikováno v:
Skin Health and Disease, Vol 3, Iss 1, Pp n/a-n/a (2023)
Abstract Background Indirect comparisons (including network meta‐analyses [NMAs]) allow us to compare benefits and risks of multiple interventions for the same clinical condition when head‐to‐head comparisons are not feasible. Objective To prov
Externí odkaz:
https://doaj.org/article/4a5dd1d92a094d769bd0ec64671838c8
Autor:
Kristian Reich, Curdin Conrad, Lars Erik Kristensen, Saxon D. Smith, Luis Puig, Phoebe Rich, Christophe Sapin, Thorsten Holzkaemper, Uffe Koppelhus, Christopher Schuster
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 3, Pp 1652-1660 (2022)
Background Nail psoriasis (NP) is common and of high importance in patients with psoriasis. Complete resolution of NP at week 24‒26 is an unambiguous nail outcome accessible for indirect treatment comparison of biologics. Objective To evaluate the
Externí odkaz:
https://doaj.org/article/d1cdd7870bc7453188b1ee1504a39778
Publikováno v:
Dermatology Research and Practice, Vol 2023 (2023)
Background. Molluscum contagiosum (MC) is a common viral skin infection primarily affecting children which is difficult to treat using available therapeutic approaches. The sulfated polysaccharide named calcium spirulan (Ca-SP) has demonstrated antiv
Externí odkaz:
https://doaj.org/article/11101540a19c439989ca2bc6099bffdf
Autor:
Kristian Reich, Lars Erik Kristensen, Saxon D. Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 2 (2022)
Introduction: The randomised, open-label, assessor-blinded, parallel-group SPIRIT-H2H trial (NCT03151551) demonstrated superiority of ixekizumab over adalimumab in simultaneously achieving improvement in joint symptoms (American College of Rheumatolo
Externí odkaz:
https://doaj.org/article/77642b2d53ea4d6391423392ca2958f9
Autor:
Alice B. Gottlieb, Atul Deodhar, Iain B. Mcinnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Kwaku Marfo, Hanno B. Richards, Luminita Pricop, Abhijit Shete, Vivek Trivedi, Deborah Keefe, Charis C. Papavassilis, Piotr Jagiello, Philemon Papanastasiou, Philip J. Mease, Mark Lebwohl
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Secukinumab, a selective interleukin (IL)-17A inhibitor, is approved for use in adult and paediatric psoriasis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis. The aim of this study was to report the long-ter
Externí odkaz:
https://doaj.org/article/df7f9d86b24a460b8b32d03dd5d1cb7c